<?xml version='1.0' encoding='utf-8'?>
<document id="29548977"><sentence text="Microdosing Cocktail Assay Development for Drug-Drug Interaction Studies." /><sentence text="Methodology for analysis of a microdosing drug cocktail designed to evaluate the contribution of drug transporters and drug metabolizing enzymes to disposition was developed using liquid chromatography-mass spectrometry-based detection" /><sentence text=" Fast and sensitive methods were developed and qualified for the quantification of statins (pitavastatin, pitavastain lactone, rosuvastatin, atorvastatin, 2-hydroxy, and 4-hydroxy atorvastatin), midazolam, and dabigatran in human plasma"><entity charOffset="92-104" id="DDI-PubMed.29548977.s3.e0" text="pitavastatin" /><entity charOffset="106-125" id="DDI-PubMed.29548977.s3.e1" text="pitavastain lactone" /><entity charOffset="127-139" id="DDI-PubMed.29548977.s3.e2" text="rosuvastatin" /><entity charOffset="141-153" id="DDI-PubMed.29548977.s3.e3" text="atorvastatin" /><entity charOffset="155-164" id="DDI-PubMed.29548977.s3.e4" text="2-hydroxy" /><entity charOffset="170-192" id="DDI-PubMed.29548977.s3.e5" text="4-hydroxy atorvastatin" /><entity charOffset="195-204" id="DDI-PubMed.29548977.s3.e6" text="midazolam" /><entity charOffset="210-220" id="DDI-PubMed.29548977.s3.e7" text="dabigatran" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e0" e2="DDI-PubMed.29548977.s3.e0" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e0" e2="DDI-PubMed.29548977.s3.e1" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e0" e2="DDI-PubMed.29548977.s3.e2" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e0" e2="DDI-PubMed.29548977.s3.e3" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e0" e2="DDI-PubMed.29548977.s3.e4" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e0" e2="DDI-PubMed.29548977.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e0" e2="DDI-PubMed.29548977.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e0" e2="DDI-PubMed.29548977.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e1" e2="DDI-PubMed.29548977.s3.e1" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e1" e2="DDI-PubMed.29548977.s3.e2" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e1" e2="DDI-PubMed.29548977.s3.e3" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e1" e2="DDI-PubMed.29548977.s3.e4" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e1" e2="DDI-PubMed.29548977.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e1" e2="DDI-PubMed.29548977.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e1" e2="DDI-PubMed.29548977.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e2" e2="DDI-PubMed.29548977.s3.e2" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e2" e2="DDI-PubMed.29548977.s3.e3" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e2" e2="DDI-PubMed.29548977.s3.e4" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e2" e2="DDI-PubMed.29548977.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e2" e2="DDI-PubMed.29548977.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e2" e2="DDI-PubMed.29548977.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e3" e2="DDI-PubMed.29548977.s3.e3" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e3" e2="DDI-PubMed.29548977.s3.e4" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e3" e2="DDI-PubMed.29548977.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e3" e2="DDI-PubMed.29548977.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e3" e2="DDI-PubMed.29548977.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e4" e2="DDI-PubMed.29548977.s3.e4" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e4" e2="DDI-PubMed.29548977.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e4" e2="DDI-PubMed.29548977.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e4" e2="DDI-PubMed.29548977.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e5" e2="DDI-PubMed.29548977.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e5" e2="DDI-PubMed.29548977.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e5" e2="DDI-PubMed.29548977.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e6" e2="DDI-PubMed.29548977.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29548977.s3.e6" e2="DDI-PubMed.29548977.s3.e7" /></sentence><sentence text=" Chromatographic separation was accomplished using reversed-phase liquid chromatography or hydrophilic interaction liquid chromatography with gradient elution and detection by tandem mass spectrometry in the positive ionization mode using electrospray ionization" /><sentence text=" The lower limit of quantitation (LLOQ) for the statins assay was 1 pg/mL for the 6 analytes with a linear range from 1 to 1000 pg/mL processing 250 μL plasma sample" /><sentence text=" The midazolam assay LLOQ was 0"><entity charOffset="5-14" id="DDI-PubMed.29548977.s6.e0" text="midazolam" /></sentence><sentence text="5 pg/mL with a linear range of 0" /><sentence text="5 to 1000 pg/mL" /><sentence text=" For the dabigatran assay, the LLOQ was 10 pg/mL with a linear range of 10 to 5000 pg/mL processing 100 μL plasma sample"><entity charOffset="9-19" id="DDI-PubMed.29548977.s9.e0" text="dabigatran" /></sentence><sentence text=" The intraday and interday precision and accuracy of the assays were within acceptable ranges, and the assays were successfully applied to support a study where a microdose cocktail was dosed to healthy human subjects for simultaneous assessment of clinical drug-drug interactions mediated by major drug transporters and CYP3A" /><sentence text="" /></document>